Frovatriptan Tablet, Film Coated
Product Images NDC 69238-1539

5 FDA label images from Amneal Pharmaceuticals Ny Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Frovatriptan (NDC 69238-1539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Frovatriptan Tablets 1)

10 (Frovatriptan Tablets 1)
Chemical structure of Frovatriptan succinate, showing the molecular formula with functional groups including an indole ring, methylamino side group, and succinate moiety as indicated by (CH2COOH)2.H2O.*
FDA Label Image

10 (Frovatriptan Tablets 2)

10 (Frovatriptan Tablets 2)
A line graph showing the estimated probability of response over time (hours) from the initial dose of Frovatriptan 2.5 mg compared to placebo. The x-axis represents time in hours up to 2 hours, and the y-axis shows the estimated probability of response as a percentage from 0% to 100%. Separate curves illustrate higher response probability for Frovatriptan versus placebo.*
FDA Label Image

10 (Frovatriptan Tablets 3)

10 (Frovatriptan Tablets 3)
A line graph showing the estimated probability of remediation or rescue medication use over 24 hours after the initial dose. It compares two groups: Placebo with a dashed line and Frovatriptan 2.5 mg with a solid line, illustrating different probabilities over time.*
FDA Label Image

1 (Frovatriptan Tablets 4)

1 (Frovatriptan Tablets 4)
Frovatriptan 2.5 mg film-coated tablets packaging label, showing multiple barcode panels. Each panel includes the proprietary name Frovatriptan, generic name Frovatriptan succinate tablet, strength 2.5 mg, Rx only, and labeler Amneal Pharmaceuticals LLC. The label notes the product is made and distributed in the USA with lot and expiration date fields.*
FDA Label Image

1 (Frovatriptan Tablets 5)

1 (Frovatriptan Tablets 5)
The packaging label for Frovatriptan Succinate Tablets 2.5 mg by Amneal Pharmaceuticals NY LLC is shown. The film-coated tablets are provided in a unit-dose carton containing 9 tablets (1 x 9). The label includes storage instructions, manufacturer and distributor information, and a barcode. Key labeling highlights include the proprietary and generic names, strength, dosage form, and a note that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.